首页> 美国卫生研究院文献>Progress in Biomaterials >Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview
【2h】

Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview

机译:通过透皮途径的聚(乳酸-共-乙醇酸)酸药物递送系统:概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In past few decades, scientists have made tremendous advancement in the field of drug delivery systems (DDS), through transdermal pathway, as the skin represents a ready and large surface area for delivering drugs. Efforts are in progress to design efficient transdermal DDS that support sustained drug release at the targeted area for longer duration in the recommended therapeutic window without producing side-effects. Poly(lactic-co-glycolic acid) (PLGA) is one of the most promising Food and Drug Administration approved synthetic polymers in designing versatile drug delivery carriers for different drug administration routes, including transdermal drug delivery. The present review provides a brief introduction over the transdermal drug delivery and PLGA as a material in context to its role in designing drug delivery vehicles. Attempts are made to compile literatures over PLGA-based drug delivery vehicles, including microneedles, nanoparticles, and nanofibers and their role in transdermal drug delivery of different therapeutic agents. Different nanostructure evaluation techniques with their working principles are briefly explained.
机译:在过去的几十年中,科学家们已经通过透皮途径在药物输送系统(DDS)领域取得了巨大的进步,因为皮肤代表了准备就绪且大面积的药物输送表面积。正在努力设计有效的透皮DDS,以支持在推荐的治疗窗口中在目标区域持续更长的持续药物释放而不会产生副作用。聚乳酸-乙醇酸共聚物(PLGA)是美国食品药品监督管理局(FDA)批准的最有前途的合成聚合物之一,可为各种给药途径(包括透皮给药)设计多功能药物输送载体。本综述简要介绍了透皮给药和PLGA作为材料在设计给药载体中的作用。尝试汇编基于PLGA的药物输送工具的文献,包括微针,纳米颗粒和纳米纤维及其在不同治疗剂的透皮药物输送中的作用。简要解释了不同的纳米结构评估技术及其工作原理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号